Market Overview

Cowen Downgrades Cameco To Market Perform

Related CCJ
How Canada Ended Up Near A Recession
Uranium Got You Down? Better Days Are Ahead, Says Cantor Fitzgerald

Analysts at Cowen & Company downgraded Cameco (NYSE: CCJ) from Outperform to Market Perform.

The target price for Cameco has been lowered from $25 to $20.

Cameco shares have gained 6.69% over the past 52 weeks, while the S&P 500 index has surged 19.89% in the same period.

Cameco's shares gained 1.58% to close at $20.56 yesterday.

Latest Ratings for CCJ

Jun 2015Goldman SachsInitiates Coverage onBuy
Apr 2015Raymond JamesUpgradesMarket PerformOutperform
Apr 2015Bank of AmericaUpgradesNeutralBuy

View More Analyst Ratings for CCJ
View the Latest Analyst Ratings

Posted-In: Cowen & CompanyDowngrades Analyst Ratings


Related Articles (CCJ)

View Comments and Join the Discussion!

Get Benzinga's Newsletters